BDUUF vs UNH: Which Stock is Better?

Side-by-side comparison of Bangkok Dusit Medical Services Public Company Limited and Unitedhealth Group Inc in 2026

Comparison Updated:

BDUUF

Bangkok Dusit Medical Services Public Company Limited

$0.65

UNH

Unitedhealth Group Inc

$323.48

Key Metrics Comparison

MetricBDUUFUNHWinner
Market Cap$10.33B$294.66BUNH
P/E Ratio21.6724.52BDUUF
EPS (TTM)$0.03$13.24UNH
Revenue Growth0.0%0.1%UNH
Gross Margin37.1%18.5%BDUUF

Analyze BDUUF

Full quant analysis

Analyze UNH

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is BDUUF or UNH a better investment?

Comparing BDUUF and UNH: Bangkok Dusit Medical Services Public Company Limited has a market cap of $10.33B while Unitedhealth Group Inc has $294.66B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between BDUUF and UNH?

BDUUF (Bangkok Dusit Medical Services Public Company Limited) and UNH (Unitedhealth Group Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: BDUUF or UNH?

Based on P/E ratios, BDUUF trades at a lower multiple (21.7x vs 24.5x).

Which is growing faster: BDUUF or UNH?

UNH has higher revenue growth at 0.1% vs 0.0% for BDUUF.

Which company is more profitable: BDUUF or UNH?

Bangkok Dusit Medical Services Public Company Limited (BDUUF) has higher gross margins at 37.1% compared to 18.5% for UNH.

Which is the larger company: BDUUF or UNH?

Unitedhealth Group Inc (UNH) is larger with a market cap of $294.66B compared to $10.33B for BDUUF.

Should I buy BDUUF or UNH in 2026?

Both BDUUF and UNH have investment merit. BDUUF trades at $0.65 while UNH trades at $323.48. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between BDUUF and UNH stock?

Key differences: Market Cap ($10.33B vs $294.66B), P/E Ratio (21.7x vs 24.5x), Revenue Growth (0.0% vs 0.1%), Gross Margin (37.1% vs 18.5%).

Popular Stock Comparisons